Blue Jays use extra roster spots on Kiner-Falefa, Tate; both active against Reds
Advertisement
Read this article for free:
or
Already have an account? Log in here »
We need your support!
Local journalism needs your support!
As we navigate through unprecedented times, our journalists are working harder than ever to bring you the latest local updates to keep you safe and informed.
Now, more than ever, we need your support.
Starting at $15.99 plus taxes every four weeks you can access your Brandon Sun online and full access to all content as it appears on our website.
Subscribe Nowor call circulation directly at (204) 727-0527.
Your pledge helps to ensure we provide the news that matters most to your community!
To continue reading, please subscribe:
Add Brandon Sun access to your Free Press subscription for only an additional
$1 for the first 4 weeks*
*Your next subscription payment will increase by $1.00 and you will be charged $20.00 plus GST for four weeks. After four weeks, your payment will increase to $24.00 plus GST every four weeks.
Read unlimited articles for free today:
or
Already have an account? Log in here »
TORONTO – Infielder Isiah Kiner-Falefa and right-hander Dillon Tate will both be active for Monday’s opener against the Cincinnati Reds, the Toronto Blue Jays announced.
Kiner-Falefa was claimed off waivers on Sunday from the Pittsburgh Pirates and has reported to the Jays. Meanwhile, Tate was selected to the Major League roster on Monday.
The moves for Kiner-Falefa and Tate make up the two additional roster spots MLB teams are granted for September — one position player and one pitcher — as they make their final push for the post-season.
In a corresponding move, right-hander Nick Sandlin has been transferred to the 60-day injured list
Kiner-Falefa was sent to Pittsburgh at the trade deadline last season after 83 games with the Jays.
Tate, on the other hand, was brought in via trade from Baltimore last season and had primarily been with triple-A Buffalo in 2025.
This report by The Canadian Press was first published Sept. 1, 2025.